REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,443,144 | -73.2% | 125,819 | -41.0% | 0.00% | -100.0% |
| Q2 2023 | $5,393,966 | -40.4% | 213,116 | -24.2% | 0.00% | -33.3% |
| Q1 2023 | $9,050,430 | +109.3% | 280,982 | +19.9% | 0.00% | +200.0% |
| Q4 2022 | $4,325,000 | -4.7% | 234,269 | +39.4% | 0.00% | -50.0% |
| Q3 2022 | $4,538,000 | +129.2% | 168,062 | +17.3% | 0.00% | +100.0% |
| Q2 2022 | $1,980,000 | -25.0% | 143,265 | +5.9% | 0.00% | 0.0% |
| Q1 2022 | $2,639,000 | +33.1% | 135,327 | +11.4% | 0.00% | 0.0% |
| Q4 2021 | $1,982,000 | -57.1% | 121,439 | -26.8% | 0.00% | 0.0% |
| Q3 2021 | $4,623,000 | -6.0% | 165,970 | +0.0% | 0.00% | -50.0% |
| Q2 2021 | $4,919,000 | +17.4% | 165,959 | +10.7% | 0.00% | +100.0% |
| Q1 2021 | $4,190,000 | -7.5% | 149,916 | -6.2% | 0.00% | -50.0% |
| Q4 2020 | $4,529,000 | +36.0% | 159,820 | +20.6% | 0.00% | +100.0% |
| Q3 2020 | $3,330,000 | -7.6% | 132,471 | -10.2% | 0.00% | -50.0% |
| Q2 2020 | $3,605,000 | +24.4% | 147,599 | -24.6% | 0.00% | 0.0% |
| Q1 2020 | $2,898,000 | -18.4% | 195,805 | -9.9% | 0.00% | +100.0% |
| Q4 2019 | $3,551,000 | +85.8% | 217,372 | +47.9% | 0.00% | 0.0% |
| Q3 2019 | $1,911,000 | +24.7% | 146,968 | +24.3% | 0.00% | 0.0% |
| Q2 2019 | $1,533,000 | -28.4% | 118,225 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $2,141,000 | +247.0% | 135,902 | +343.6% | 0.00% | – |
| Q4 2018 | $617,000 | -15.8% | 30,637 | +3.8% | 0.00% | – |
| Q3 2018 | $733,000 | -1.5% | 29,514 | +8.9% | 0.00% | – |
| Q2 2018 | $744,000 | -56.7% | 27,112 | -51.3% | 0.00% | -100.0% |
| Q1 2018 | $1,717,000 | -25.6% | 55,717 | -13.8% | 0.00% | 0.0% |
| Q4 2017 | $2,309,000 | +264.2% | 64,614 | +181.1% | 0.00% | – |
| Q3 2017 | $634,000 | +5.0% | 22,984 | +0.3% | 0.00% | – |
| Q2 2017 | $604,000 | +28.0% | 22,904 | +1.0% | 0.00% | – |
| Q1 2017 | $472,000 | +0.6% | 22,679 | 0.0% | 0.00% | – |
| Q4 2016 | $469,000 | +94.6% | 22,679 | +64.2% | 0.00% | – |
| Q1 2016 | $241,000 | -83.2% | 13,815 | -67.1% | 0.00% | -100.0% |
| Q4 2015 | $1,433,000 | -66.5% | 41,957 | -83.4% | 0.00% | -50.0% |
| Q4 2014 | $4,277,000 | -5.6% | 252,494 | +7.7% | 0.00% | -33.3% |
| Q3 2014 | $4,533,000 | -27.6% | 234,492 | +27.3% | 0.00% | -25.0% |
| Q2 2014 | $6,264,000 | +20.9% | 184,221 | +12.0% | 0.00% | +33.3% |
| Q1 2014 | $5,180,000 | – | 164,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |